Korro Bio
Drug Discovery
Korro Bio valuation and funding history | Last updated: January 5, 2022 | 1 funding rounds
Current Valuation
N/A
As of January 5, 2022
Total Funding Raised
N/A
Across 1 round
Last Round
Early Stage VC (Series B)
$116.0M
Last Funding
Jan 2022
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| January 5, 2022 | Early Stage VC (Series B) | $116.0M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Korro Bio is currently valued at N/A as of January 5, 2022.
What is Korro Bio Worth in 2026?
Korro Bio is a leading private company in the Drug Discovery sector. Track Korro Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Korro Bio Valuation is Determined
Private company valuations like Korro Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.